Form 4: Quaker Chemical Director William H. Osborne Reports Routine Equity Transactions and New RSU Grant

Quaker Chemical Corp. Director William H. Osborne has reported the vesting of restricted stock units and dividend equivalent rights, along with the grant of new time-based restricted stock units as part of his 2025 compensation.

Summary

• William H. Osborne, a Director of Quaker Chemical Corp. (KWR), reported transactions on May 31, 2025, and June 1, 2025, as part of a Form 4 filing.
• On May 31, 2025, 716 shares of Common Stock were acquired directly upon the conversion of restricted stock units (RSUs) that vested 100% on that date.
• Additionally, on May 31, 2025, 9 shares of Common Stock were acquired directly due to the settlement of dividend equivalent rights (DERs) associated with the vesting of restricted stock units.
• On June 1, 2025, Mr. Osborne was granted 1,198 time-based restricted stock units under the Company's Long-Term Performance Incentive Plan, as part of his 2025 non-executive director compensation.
• These newly granted 1,198 restricted stock units are scheduled to vest 100% on May 31, 2026, and will accrue dividend equivalent rights.
• Following these transactions, Mr. Osborne directly holds 1,198 restricted stock units and indirectly holds 5,560 shares of Common Stock through a revocable trust agreement.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of insider equity transactions (vesting and new grants) and does not contain information that would significantly alter the company's financial outlook or operational status. It is a neutral, factual report.

Positives

• The vesting of 716 restricted stock units and 9 dividend equivalent rights represents a realization of previously granted equity compensation for the director.
• The grant of 1,198 new restricted stock units aligns the director's interests with long-term shareholder value through future equity participation.

Future Outlook

The document indicates that the 1,198 restricted stock units granted on June 1, 2025, are expected to vest 100% on May 31, 2026, and will accrue dividend equivalent rights until that time.

Industry Context

This Form 4 filing reflects routine equity compensation practices for non-executive directors in publicly traded companies, where a portion of compensation is often granted in the form of restricted stock units to align director interests with long-term company performance.

Related Party Transactions

• The grant of time-based restricted stock units to William H. Osborne, a non-executive director, as part of his 2025 compensation, represents a transaction between the company and a related party (director).

Stakeholder Impact

• Shareholders: The grant of new restricted stock units to a director aligns their interests with long-term shareholder value, as the value of these units is tied to the company's stock performance. The vesting of previous units represents a routine dilution from equity compensation plans.

Next Steps

• The 1,198 restricted stock units granted on June 1, 2025, are scheduled to vest on May 31, 2026, at which point they will convert into common stock.

Key Dates

Keywords

Quaker Chemical Corp, KWR, SEC Form 4, Insider Trading, Restricted Stock Units, RSU, Dividend Equivalent Rights, Director Compensation, Equity Compensation, Beneficial Ownership, Corporate Governance